Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non–ST-elevation acute coronary syndrome: results of the …

…, V Descotes-Genon, J Silvain, N Braik, R Chopard… - Circulation, 2016 - Am Heart Assoc
Background: No randomized study has investigated the value of optical coherence tomography
(OCT) in optimizing the results of percutaneous coronary intervention (PCI) for non–ST-…

Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years

…, F Rouleau, S Chocron, R Chopard… - European journal of …, 2019 - Wiley Online Library
Aims The MITRA‐FR trial showed that among symptomatic patients with severe secondary
mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for …

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients

…, C Chirouze, F Schiele, R Chopard… - European …, 2020 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19) may predispose to venous
thromboembolism. We determined factors independently associated with computed tomography …

Clinical outcomes and safety of transfemoral aortic valve implantation under general versus local anesthesia: subanalysis of the French Aortic National CoreValve and …

…, JL Dubois-Rande, R Chopard… - Circulation …, 2014 - Am Heart Assoc
Background— Transcatheter aortic valve implantation (TAVI) performed under local anesthesia
(LA) is becoming increasingly common. We aimed to compare the clinical outcomes in …

Diagnosis and treatment of lower extremity venous thromboembolism: a review

R Chopard, IE Albertsen, G Piazza - Jama, 2020 - jamanetwork.com
Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20…

Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the …

R Chopard, E Teiger, N Meneveau, S Chocron… - Cardiovascular …, 2015 - jacc.org
Objectives The aim of this study was to determine baseline characteristics and clinical outcomes
of patients with pre-existing atrial fibrillation (AF) and of patients who presented with new…

C-reactive protein improves risk prediction in patients with acute coronary syndromes

…, N Meneveau, MF Seronde, R Chopard… - European heart …, 2010 - academic.oup.com
Aims Elevated C-reactive protein level is a risk marker in patients with acute coronary
syndromes (ACSs), but current risk score systems do not consider this factor. We studied the …

Anemia for risk assessment of patients with acute coronary syndromes

…, V Descotes-Genon, J Oettinger, R Chopard… - The American journal of …, 2009 - Elsevier
In patients admitted with acute coronary syndromes, those with anemia are at higher risk.
However, current risk score systems do not take into account the presence of anemia. The …

Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction …

…, V Descotes-Genon, J Dutheil, R Chopard… - Clinical research in …, 2009 - Springer
Background Early management of patients with patent infarct-related artery (IRA) and optimal
ST resolution in ST elevation myocardial infarction (STEMI) has never been assessed. We …

Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate-to high-risk pulmonary embolism

…, O Ider, MF Seronde, R Chopard… - European heart …, 2013 - academic.oup.com
Background We evaluated prognostic value at 6 months of residual pulmonary vascular
obstruction (RPVO) measured before discharge in patients with intermediate- or high-risk …